3.0
8 Aug 2024
Current employee
Recommend
CEO approval
Business outlook
Pros
Strong community brand, portfolio diversity. Pharma, Crop science, Consumer.
Cons
Company facing significant headwinds as a result of lack of innovation and operational investment. Impacting culture and retention of IP.